InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Wentworth Kerry, Directeur Réglementaire. Officer active across 2 companies, notably Flexion Therapeutics Inc. In total, 9 disclosures have been recorded. Split: 1 buy · 3 sells. Total volume traded: €1m. Activity tracked since 21 June 2021. The latest transaction was filed on 17 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Wentworth Kerry is Directeurréglementaire and has reported 9 filings in total. Across the 9 filings available, the recorded transactions run from 2021-06-28 to 2026-04-21, with EUR 40,290 of purchases and EUR 2,013,929 of sales, and the most frequent transaction type is Levée d'options. He is linked to Nuvation Bio Inc. and Flexion Therapeutics Inc.